Tag: antipsychotic side effects
Cancer Risk Higher for Those on Clozapine
The antipsychotic clozapine, considered the âgold-standardâ treatment for psychosis, was found to increase the risk of blood and lymph system cancers.
Children on Antipsychotics at Risk for Weight Gain and Diabetes
From U.S. News: "Children and adolescents treated with antipsychotic medications experience weight gain and develop an increased risk of diabetes, according to a new...
Researchers Discover How Antipsychotics Lead To Parkinsonism
A new study published this month in the journal Neuron identifies the mechanism by which antipsychotic drugs can induce parkinsonism, a condition involving movement...
Moving Forward in the Science of Psychiatric Medication Discontinuation/Reduction
This week Live & Learn launched a research study on the experience of people labeled with mental disorders who have tried to stop taking psychiatric medications. This project -- the Psychiatric Medication Discontinuation/Reduction (PMDR) Study -- aims to understand the process of coming off psychiatric medications in order to better support those who choose to do so. The study seeks to answer the question: What helps people stop their psychiatric medications? What gets in the way of stopping?
The Evidence-Based Mind of Psychiatry on Display
The writings of Pies and his colleagues, I believe, provide a compelling case study of cognitive dissonance. Cognitive dissonance arises when people are presented with information that creates conflicted psychological states, challenging some belief they hold dear, and people typically resolve dissonant states by sifting through information in ways that protect their self-esteem and their financial interests. It is easy to see that process operating here.
Review Links Antipsychotics with Risk for Heart Attacks
A systematic review published this week in the British Journal of Clinical Pharmacology found that patients taking antipsychotic drugs were at nearly twice the risk...
New Research into Antipsychotic Discontinuation And Reduction: the RADAR programme
For a long time I have felt that there just isnât a good enough and long enough study on the pros and cons of long-term antipsychotic treatment versus reduction and discontinuation in people who have psychotic disorders, including those who are classified as having schizophrenia. Moreover, there are increasing reasons to be worried about the effects of long-term treatment with antipsychotics. I put this case to the UKâs National Institute of Health Research recently, and proposed that they fund a trial to assess the long-term outcomes of a gradual programme of antipsychotic reduction compared with standard âmaintenance treatment.â The NIHR agreed that this was an important issue, and that a new trial was urgently needed. The RADAR (Research into Antipsychotic Discontinuation And Reduction) study officially started in January 2016.
âIs It Her Hormones?â A Case of Psychiatry Missing the Mark
The case of âBethâ depicts, almost innocently, the trials and tribulations of a well-adjusted, talented 15-year-old who developed depression, paranoia, panic attacks, and self-injurious and homicidal behavior, and âbipolar disorderâ after being prescribed antidepressants, and then antipsychotics. After Beth decided - on her own - to discontinue psychotropic medications in favor of hormone therapy, she remained free of psychiatric symptoms.
Identifying Psychiatric Drugs Leading to Emergency Room Visits
More than ten-percent of adults in the United States are currently prescribed at least one psychiatric medication but there is currently a lack of research on the prevalence of adverse drug events (ADEs) associated with these prescriptions outside of clinical trials.
Antipsychotics Withdrawal, Part 3
So, thanks to everyone who has read and commented on my stories of reentry into the mental health system. I have now had eight nights of very good sleep and my mental health symptoms are back to the baseline. Baseline for me means I only get separated from consensus reality when a significant trauma occurs at the same time I'm having a pretty good sleep deficit. Usually I can manage it myself simply by being aggressive about handling â and increasing â the sleep. So this time I was unable to break that cycle and got some more drugs to help.
On Relaxing Off-Label Meds:Â Do the Opposite. Especially for Children. Especially Antipsychotics
The US Food and Drug Administration has announced that there will soon be a public meeting to explore providing drug companies with greater flexibility in promoting off-label indications to doctors. When it comes to prescribing medications to children, and particularly psychiatric medications, this is a bad idea. I write both as a former consultant to the pharmaceutical industry, and as a father who lost a son to the toxic effects of antipsychotics prescribed off-label.
What To Do With Advocates Who Refuse To Learn About Drug...
I get a lot of ideas from other advocates from online forums like the Alternatives Facebook discussion group,  where we have a gathering of about...